Novo Nordisk AS 2023 AR2
The report highlights Novo Nordisk's centenary year in 2023, marked by significant growth driven by high demand for its GLP-1-based therapies, Ozempic and Wegovy. To meet this demand, the company announced investments of over DKK 75 billion to expand global production capacity. On the sustainability front, Novo Nordisk progressed toward its target of net zero emissions across its value chain by 2045, with all production sites sourcing 100% renewable power since 2020. Additionally, the company expanded its social impact by reaching 41.6 million patients with diabetes and obesity care products and launching a new partnership with Aspen Pharmaceuticals to produce human insulin in Africa.
Company: Novo Nordisk AS
Sector: Health Care
Country: Denmark
Year: 2023
Type: AR2
Pages: 112
Novo Nordisk AS
Annual Report
The report highlights Novo Nordisk's centenary year in 2023, marked by significant growth driven by high demand for its GLP-1-based therapies, Ozempic and Wegovy. To meet this demand, the company announced investments of over DKK 75 billion to expand global production capacity. On the sustainability front, Novo Nordisk progressed toward its target of net zero emissions across its value chain by 2045, with all production sites sourcing 100% renewable power since 2020. Additionally, the company expanded its social impact by reaching 41.6 million patients with diabetes and obesity care products and launching a new partnership with Aspen Pharmaceuticals to produce human insulin in Africa.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees